Product overview

AiCure is an AI and advanced data analytics company that monitors patient behavior and enables remote patient engagement in clinical trials. This is completed through remote patient engagement and assessments, including measuring digital biomarkers and real-time monitoring of patient dosing to confirm medication adherence. Founded in 2010, AiCure has received funding from the National Institutes of Health (NIH), as well as other investors. In recent years, AiCure has focused in part on applications for oncology clinical trials.

How it works

The AiCure Dosing Support solution works through an application on a patient’s smartphone. The system alerts alerting patients when it’s time to take medication and walks them through how to do so correctly. The smartphone’s recording features work with AiCure’s artificial intelligence program to confirm whether a dose has been taken. This information is transmitted to the patient’s care team.

Fit for purpose

Patient burden50%
50%
Provider burden20%
20%
Tech requirements60%
60%
Barriers to entry10%
10%
Accuracy80%
80%
Evidence80%
80%

Specifications

DS and DR-TB patients100%
100%
Electricity requirements100%
100%
Dosing histories80%
80%
Reminders10%
10%
Reporting80%
80%
Portability80%
80%
Data integration80%
80%

Advantages

  • High level of pill-taking accuracy
  • Does not require a provider to confirm that doses were taken
  • Has been used previously for TB

Disadvantages

  • Requires a smartphone
  • Does not allow export of data to other platforms
  • Has not been used for TB in LMICs

Access

For more information, please visit the AiCure website.

Menu